Kymera Therapeutics
Watertown, Massachusetts, United States
Veronica Campbell joined Kymera Therapeutics in November 2016 and currently serves as Senior Director of Immunology. She has over 20 years of experience in early drug discovery and translational medicine including efforts to advance programs from lead optimization to development candidate and has contributed significantly in multiple IND submissions. Prior to Kymera, she held positions in early discovery and translational medicine at Infinity Pharmaceuticals and Millenium Pharmaceuticals as well as early-stage biotechnology companies. While at Infinity, she worked on proof-of-concept human trials that led to the approval of Copiktra®(duvelisib) for the treatment of relapsed or refractory CLL/SLL. Veronica earned her degree in Sciences from Northeastern University.
Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
